SARS-CoV-2 Vaccine (Vero Cells), Inactivated

BIOLOGICAL3 trials

Sponsors

Shenzhen Kangtai Biological Products Co., LTD

Conditions

COVID-19

Phase 1

Clinical Trial of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Population Aged 3 to 17 Years(COVID-19)

Shenzhen Kangtai Biological Products Co., LTDCOVID-19

Start: 2021-08-31End: 2022-10-31Target: 84Updated: 2021-08-18

Phase 2

Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 3 to 17 Years(COVID-19)

Shenzhen Kangtai Biological Products Co., LTDCOVID-19

Start: 2021-09-30End: 2023-04-30Target: 480Updated: 2021-08-18

Phase 3

A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)

Shenzhen Kangtai Biological Products Co., LTDCOVID-19

Start: 2021-05-31End: 2022-11-30Target: 28000Updated: 2021-04-22